ロード中...
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
BACKGROUND: Hereditary angioedema is characterized by recurrent attacks of angioedema of the skin, larynx, and gastrointestinal tract. Bradykinin is the key mediator of symptoms. Icatibant is a selective bradykinin B2 receptor antagonist. METHODS: In two double-blind, randomized, multicenter trials,...
保存先:
| 出版年: | N Engl J Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662377/ https://ncbi.nlm.nih.gov/pubmed/20818888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0906393 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|